Stuck In Reverse: Another Start-up Takes Reverse Merger Route To Public Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal results in unlikely combination of antbiotics maker Replidyne and device firm Cardiovascular Systems.